Bank Julius Baer & Co. Ltd, Zurich Medicinova Inc Transaction History
Bank Julius Baer & Co. Ltd, Zurich
- $25.6 Billion
- Q3 2024
A detailed history of Bank Julius Baer & Co. Ltd, Zurich transactions in Medicinova Inc stock. As of the latest transaction made, Bank Julius Baer & Co. Ltd, Zurich holds 16,027 shares of MNOV stock, worth $32,855. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,027
Previous 17,073
6.13%
Holding current value
$32,855
Previous $24,000
37.5%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding MNOV
# of Institutions
31Shares Held
4.83MCall Options Held
9.4KPut Options Held
6K-
Essex Woodlands Management, Inc. The Woodlands, TX1.11MShares$2.27 Million0.67% of portfolio
-
Black Rock Inc. New York, NY695KShares$1.42 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA623KShares$1.28 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA506KShares$1.04 Million0.0% of portfolio
-
Citigroup Inc448KShares$918,3110.0% of portfolio
About MEDICINOVA INC
- Ticker MNOV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,046,200
- Market Cap $101M
- Description
- MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...